Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe.
PURPOSE Using real-world data (RWD), we assessed the impact of diagnostic regulatory pathways on activation timelines and biomarker testing implementation in biomarker-driven clinical trials across Europe. METHODS RWD from 132 Clinical Performance Study Applications (PSAs) and Ethics Committee (EC) submissions across...